Surviving irradiated cells increase the expression of death receptors, including Fas, and upregulate major histocompatibility class 1 molecules, improving their recognition and killing by activated tumor antigen-specific CD8+ T-cells [10]. This evidence concerns the gene CD8A and neoplasm.